Lymphovascular Invasion is Independently Associated With Poor Prognosis in Patients With Localized Upper Urinary Tract Urothelial Carcinoma Treated Surgically

Journal of Urology

Volumn 178, Issue 6, 2007, Pages 2291-2296

  Saito, Kazutaka ^a   Kawakami, Satoru ^a   Fujii, Yasuhisa ^a   Sakura, Mizuaki ^a   Masuda, Hitoshi ^a   Kihara, Kazunori ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

carcinoma; lymph nodes; neoplasm invasiveness; ureter; urothelium

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; URINARY TRACT CARCINOMA;

AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC VESSELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; URINARY BLADDER NEOPLASMS; UROLOGIC NEOPLASMS;

EID: 35748954340     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.08.019     Document Type: Article

References (19)

1. Schmauz R., and Cole P. Epidemiology of cancer of the renal pelvis and ureter. J Natl Cancer Inst 52 (1974) 1431
2. Munoz J.J., and Ellison L.M. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol 164 (2000) 1523
3. Guinan P., Vogelzang N.J., Randazzo R., Sener S., Chmiel J., Fremgen A., et al. Renal pelvic cancer: a review of 611 patients treated in Illinois 1975-1985. Cancer Incidence and End Results Committee. Urology 40 (1992) 393
4. Hall M.C., Womack S., Sagalowsky A.I., Carmody T., Erickstad M.D., and Roehrborn C.G. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 52 (1998) 594
5. Sternberg C.N., de Mulder P.H., Schornagel J.H., Theodore C., Fossa S.D., van Oosterom A.T., et al. Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European Organization for Research and Treatment of Cancer Protocol no. 30924. J Clin Oncol 19 (2001) 2638
6. Geller N.L., Sternberg C.N., Penenberg D., Scher H., and Yagoda A. Prognostic factors for survival of patients with advanced urothelial tumors treated with methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy. Cancer 67 (1991) 1525
7. Saito K., Fujii Y., Kawakami S., Hayashi T., Arisawa C., Koga F., et al. Increased expression of sialyl-Lewis A correlates with poor survival in upper urinary tract urothelial cancer patients. Anticancer Res 23 (2003) 3441
8. Ohtsuka Y., Kawakami S., Fujii Y., Koga F., Saito K., Ando N., et al. Loss of uroplakin III expression is associated with a poor prognosis in patients with urothelial carcinoma of the upper urinary tract. BJU Int 97 (2006) 1322
9. Corrado F., Mannini D., Ferri C., Corrado G., Bertoni F., Bacchini P., et al. The prognostic significance of DNA ploidy pattern in transitional cell cancer of the renal pelvis and ureter: continuing follow-up. Eur Urol 21 suppl (1992) 48
10. Ozsahin M., Zouhair A., Villa S., Storme G., Chauvet B., Taussky D., et al. Prognostic factors in urothelial renal pelvis and ureter tumours: a multicentre Rare Cancer Network study. Eur J Cancer 35 (1999) 738
11. Park S., Hong B., Kim C.S., and Ahn H. The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract. J Urol 171 (2004) 621
12. Hong B., Park S., Hong J.H., Kim C.S., Ro J.Y., and Ahn H. Prognostic value of lymphovascular invasion in transitional cell carcinoma of upper urinary tract. Urology 65 (2005) 692
13. Kikuchi E., Horiguchi Y., Nakashima J., Hatakeyama N., Matsumoto M., Nishiyama T., et al. Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tract. J Urol 174 (2005) 2120
14. Saito K., Kawakami S., Ohtsuka Y., Fujii Y., Masuda H., Kumagai J., et al. The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically. BJU Int 100 (2007) 269
15. Sakuragi N., Takeda N., Hareyama H., Fujimoto T., Todo Y., Okamoto K., et al. A multivariate analysis of blood vessel and lymph vessel invasion as predictors of ovarian and lymph node metastases in patients with cervical carcinoma. Cancer 88 (2000) 2578
16. Shariat S.F., Khoddami S.M., Saboorian H., Koeneman K.S., Sagalowsky A.I., Cadeddu J.A., et al. Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomy. J Urol 171 (2004) 1122
17. Herman C.M., Wilcox G.E., Kattan M.W., Scardino P.T., and Wheeler T.M. Lymphovascular invasion as a predictor of disease progression in prostate cancer. Am J Surg Pathol 24 (2000) 859
18. Lotan Y., Gupta A., Shariat S.F., Palapattu G.S., Vazina A., Karakiewicz P.I., et al. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 23 (2005) 6533
19. Olgac S., Mazumdar M., Dalbagni G., and Reuter V.E. Urothelial carcinoma of the renal pelvis: a clinicopathologic study of 130 cases. Am J Surg Pathol 28 (2004) 1545